Firms Bristle At Labeling Requirements For Patient-Preference Data
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers say labeling recommendations in FDA's recent draft guidance on applying patient-preference information for device submissions is burdensome and may lead to confusion among doctors and patients. Meanwhile, Public Citizen says FDA should abandon the guidance because it lowers approval standards.
You may also be interested in...
Final Guidance Encourages Use Of Patient Preference In Device Applications
US FDA released a final guidance aimed at helping sponsors and other stakeholders interested in using patient-preference information to make their case for a device application. The agency has decided to keep its labeling recommendation in the final guidance despite industry objections.
Guidance: What The Patient Prefers, And How To Make It Part Of Your FDA Submission
FDA draft guidance lays out how to collect patient preference data and how to present the preferences on device labels. The guidance supports a growing emphasis by FDA to formally incorporate patient input into regulatory decision-making.
Device Consortium Tries To Shed Light on Patient Risk-Benefit Preferences
The public-private Medical Device Innovation Consortium issued a report outlining strategies for incorporating patient preference data into device applications.